RHL Group
DYN icon

RHL Group’s Dyne Therapeutics DYN Stock Holding History

RHL Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16 Buy
+1
New +$23 ﹤0.01% 365

Other funds holding DYN

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.2B AUM 30.02% 1-Year Est. Return

RHL Group's DYN Position: Q3 2026 in Review

RHL Group opened a new position in Dyne Therapeutics (DYN) in Q3 2026: 1 share worth $16. The stake represents ﹤0.01% of the portfolio and ranks #365 among its holdings.

64 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • RHL Group held 1 share of Dyne Therapeutics worth $16 as of Q3 2026.
  • Dyne Therapeutics was a new RHL Group position in Q3 2026.
  • Dyne Therapeutics made up ﹤0.01% of RHL Group's portfolio in Q3 2026, its #365 holding.
  • 64 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on RHL Group's 13F filing for Q3 2026, filed 4 Nov 2026.